NasdaqCM - Nasdaq Real Time Price USD
Jupiter Neurosciences, Inc. (JUNS)
0.6395
+0.0190
+(3.06%)
At close: April 22 at 4:00:01 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-3,911.0040
-3,911.0040
-480.9530
-1,248.5040
-1,735.0460
Financing Cash Flow
7,652.0360
7,652.0360
445
982.3330
1,857.6500
End Cash Position
3,769.5100
3,769.5100
28.4780
64.4310
330.6020
Interest Paid Supplemental Data
147.7760
147.7760
28.1280
81.5000
1.0640
Issuance of Capital Stock
9,875.2130
9,875.2130
55
--
--
Issuance of Debt
138.5000
138.5000
390
982.3330
527.6500
Repayment of Debt
-2,361.6770
-2,361.6770
--
--
--
Free Cash Flow
-3,911.0040
-3,911.0040
-480.9530
-1,248.5040
-1,735.0460
12/31/2021 - 12/3/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MIST Milestone Pharmaceuticals Inc.
1.0600
+4.95%
APVO Aptevo Therapeutics Inc.
0.6934
+9.08%
CNTB Connect Biopharma Holdings Limited
0.6998
-6.31%
CHRO Channel Therapeutics Corporation
1.5500
+8.39%
PHIO Phio Pharmaceuticals Corp.
2.5100
-11.31%
OBIO Orchestra BioMed Holdings, Inc.
2.8600
+0.70%
BCTX BriaCell Therapeutics Corp.
5.35
+27.68%
CMND Clearmind Medicine Inc.
1.0000
-4.76%
DWTX Dogwood Therapeutics, Inc.
5.46
+1.68%
PRTG Portage Biotech Inc.
9.86
+8.47%